Barclays Maintains Equal-Weight on CME Gr, Raises Price Target to $209
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Benjamin Budish maintains an Equal-Weight rating on CME Group (NASDAQ:CME) and raises the price target from $208 to $209.
July 25, 2024 | 12:30 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Barclays analyst Benjamin Budish maintains an Equal-Weight rating on CME Group and raises the price target from $208 to $209.
The Equal-Weight rating suggests a neutral stance, indicating that the stock is expected to perform in line with the market. The slight increase in the price target from $208 to $209 shows a marginally positive outlook but is not significant enough to drive a strong price movement.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100